Back to Results
First PageMeta Content
MODDERN Cures Act / Biosimilar / Food and Drug Administration / Pharmaceutical industry / Clinical trial / Dormant Therapy / Drug Price Competition and Patent Term Restoration Act / Pharmaceutical drug / Patient safety organization / Pharmaceutical sciences / Pharmacology / Clinical research


National Health Council 1730 M Street NW, Suite 500, Washington, DC[removed] ■ [removed] ■ www.nationalhealthcouncil.org ■ [removed] Response to Request for Information on the Strategy for American In
Add to Reading List

Document Date: 2014-10-31 09:11:05

Open Document

File Size: 310,65 KB

Share Result on Facebook

City

Washington / DC / /

Company

Texas Law Review / Meredith / /

Country

United States / /

/

Event

FDA Phase / /

Facility

The Institute of Medicine / Patient-Centered Outcomes Research Institute / /

IndustryTerm

biotechnology / pharmaceutical patents / unapproved medical products / pharmaceutical industry / prevention of various diseases / reference product / investigational products / health insurance / pre-approval communications / pharmaceutical / pharmaceutical and biopharma industry / /

MedicalCondition

rare diseases / cancer / disease / chronic disease / diseases / chronic diseases / early-stage diseases / select diseases / /

Organization

Congress / Institutional Review Board / Food and Drug Administration / Patient-Centered Outcomes Research Institute / Institute of Medicine / Federal Trade Commission / National Economic Council / office of Science and Technology Policy / Bureau of Economic Research / National Health Council / /

Person

Leonard Lance / /

/

Position

Patch Forward / researcher / Representative / /

Product

Patient-Focused Drug / Forward / /

ProgrammingLanguage

DC / /

PublishedMedium

Texas Law Review / /

Technology

pharmacogenetics / biotechnology / drug design / drug development / /

URL

http /

SocialTag